Ban Zhi Lian and Breast Cancer

It was observed that many of the women who took Chinese herbs, including Ban Zhi Lian, responded well to the herbs and even experienced a relatively good quality of life. This is the basis for the clinical trial of BZL101, being conducted in major medical centers. The data, which were presented at the American Society of Clinical Oncology 44th Annual Meeting, showed that BZL101, at higher doses, continues to have a favorable safety and tolerability profile and show ongoing evidence of clinical activity in women with advanced breast cancer. Read Article in Medical News Today